CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection. Issue 12 (24th October 2019)

• Record Type: Journal Article
• Authors: Bai, Lanlan; Sato, Hirotaka; Kubo, Yoshinao; Wada, Satoshi; Aida, Yoko
• Is Part Of: FASEB journal. Volume 33:Issue 12(2019)
• Page Start: 14516
• Page End: 14527
• Publication Date: 2019-10-24
• Subjects: BLV envelope -- binding ability -- colocalization -- syncytium formation; Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.201901528R
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract : Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis, the most common neoplastic disease of cattle, which is closely related to human T‐cell leukemia viruses. BLV has spread worldwide and causes a serious problem for the cattle industry. The cellular receptor specifically binds with viral envelope glycoprotein (Env), and this attachment mediates cell fusion to lead virus entry. BLV Env reportedly binds to cationic amino acid transporter 1 (CAT1)/solute carrier family 7 member 1 (SLC7A1), but whether the CAT1/SLC7A1 is an actual receptor for BLV remains unknown. Here, we showed that CAT1 functioned as an infection receptor, interacting with BLV particles. Cells expressing undetectable CAT1 levels were resistant to BLV infection but became highly susceptible upon CAT1 overexpression. CAT1 exhibited specific binding to BLV particles on the cell surface and colocalized with the Env in endomembrane compartments and membrane. Knockdown of CAT1 in permissive cells significantly reduced binding to BLV particles and BLV infection. Expression of CAT1 from various species demonstrated no species specificity for BLV infection, implicating CAT1 as a functional BLV receptor responsible for its broad host range. These findings provide insights for BLV infection and for developing new strategies for treating BLV and preventing its spread.—Bai, L., Sato, H., Kubo, Y., Wada, S., Aida, Y. CAT1/SLC7A1 acts as a cellular receptor for bovine leukemia virus infection. FASEB J. 33, 14516‐14527 (2019). www.fasebj.org